Trustcore Financial Services, LLC Impel Pharmaceuticals Inc Transaction History

Trustcore Financial Services, LLC

  • $1.13 Billion
  • Q4 2022

A detailed history of Trustcore Financial Services, LLC transactions in Impel Pharmaceuticals Inc stock. As of the latest transaction made, Trustcore Financial Services, LLC holds 14,407 shares of IMPL stock, worth $288. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,407
Previous 13,407 7.46%
Holding current value
$288
Previous $65,000 16.92%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$2.59 - $4.0 $2,590 - $4,000
1,000 Added 7.46%
14,407 $54,000
Q3 2021

Nov 08, 2021
BUY
$8.38 - $26.13 $112,350 - $350,324
13,407 New
13,407 $163,000

Others Institutions Holding IMPL

# of Institutions
1
Shares Held
14.4K
Call Options Held
0
Put Options Held
0
View Full List

About IMPEL PHARMACEUTICALS INC

IMPL Quotes by TradingView
  • Ticker IMPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,738,800
  • Market Cap $475K
  • Description
  • Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...
More about IMPL
Track This Portfolio

Track Trustcore Financial Services, LLC Portfolio

Follow Trustcore Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustcore Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trustcore Financial Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email